Kwak LW - Search Results

1

Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes.

Weng J, Cha SC, Matsueda S, Alatrash G, Popescu MS, Yi Q, Molldrem JJ, Wang M, Neelapu SS, Kwak LW. Weng J, et al. Among authors: kwak lw. Clin Cancer Res. 2011 Sep 15;17(18):5945-52. doi: 10.1158/1078-0432.CCR-11-0970. Epub 2011 Aug 3. Clin Cancer Res. 2011. PMID: 21813633 Free PMC article.

2

Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine.

Neelapu SS, Baskar S, Kwak LW. Neelapu SS, et al. Among authors: kwak lw. J Cancer Res Clin Oncol. 2001 Oct;127 Suppl 2:R14-9. doi: 10.1007/BF01470994. J Cancer Res Clin Oncol. 2001. PMID: 11768619

3

Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.

Ruffini PA, Neelapu SS, Kwak LW, Biragyn A. Ruffini PA, et al. Among authors: kwak lw. Haematologica. 2002 Sep;87(9):989-1001. Haematologica. 2002. PMID: 12217812 Review.

4

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.

Grube M, Rezvani K, Wiestner A, Fujiwara H, Sconocchia G, Melenhorst JJ, Hensel N, Marti GE, Kwak LW, Wilson W, Barrett JA. Grube M, et al. Among authors: kwak lw. Clin Cancer Res. 2004 Feb 1;10(3):1047-56. doi: 10.1158/1078-0432.ccr-03-0075. Clin Cancer Res. 2004. PMID: 14871984

5

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion.

Kwak LW, Neelapu SS, Bishop MR. Kwak LW, et al. Semin Oncol. 2004 Feb;31(1):37-46. doi: 10.1053/j.seminoncol.2003.11.001. Semin Oncol. 2004. PMID: 14970936 Review.

6

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.

Malyguine A, Strobl SL, Shafer-Weaver KA, Ulderich T, Troke A, Baseler M, Kwak LW, Neelapu SS. Malyguine A, et al. Among authors: kwak lw. J Transl Med. 2004 Mar 29;2(1):9. doi: 10.1186/1479-5876-2-9. J Transl Med. 2004. PMID: 15050026 Free PMC article.

7

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis.

Ruffini PA, Biragyn A, Coscia M, Harvey LK, Cha SC, Bogen B, Kwak LW. Ruffini PA, et al. Among authors: kwak lw. J Leukoc Biol. 2004 Jul;76(1):77-85. doi: 10.1189/jlb.1003481. Epub 2004 Apr 9. J Leukoc Biol. 2004. PMID: 15075363

8

Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo.

Biragyn A, Ruffini PA, Coscia M, Harvey LK, Neelapu SS, Baskar S, Wang JM, Kwak LW. Biragyn A, et al. Among authors: kwak lw. Blood. 2004 Oct 1;104(7):1961-9. doi: 10.1182/blood-2004-02-0637. Epub 2004 Jun 10. Blood. 2004. PMID: 15191951 Free article.

9

Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.

Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW. Neelapu SS, et al. Among authors: kwak lw. Clin Cancer Res. 2004 Dec 15;10(24):8309-17. doi: 10.1158/1078-0432.CCR-04-1071. Clin Cancer Res. 2004. PMID: 15623607 Clinical Trial.

10

Monocyte-derived dendritic cells: a promising armament for immunotherapy in human malignancies.

Yi Q, Kwak LW. Yi Q, et al. Among authors: kwak lw. Clin Cancer Res. 2005 Feb 1;11(3):966-7. Clin Cancer Res. 2005. PMID: 15709160 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters